ArticleFrontiers in artificial intelligence2025
Leveraging multi-scale feature integration in UNet and FPN for semantic segmentation of lung nodules.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of CT Intensity and Contrast Variability on Deep-Learning-Based Lung-Nodule Detection: A Systematic Review of Preprocessing and Harmonization Strategies (2020-2025).Diagnostics (Basel, Switzerland) · 2026Review
- Feature stabilization in convolutional neural networks using Proportional Integral Controller for lung nodule classification.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Lung cancer remains as an important source of cancer-related mortality worldwide, demonstrating a substantial challenge to public health systems. The absence of evident symptoms in the early stages makes timely diagnosis of lung cancer challenging. Early identification and treatment will reduce the mortality rate caused by lung cancer. Abnormal growths identified as lung or pulmonary nodules can be found in the lungs and some of these could be malignant. A Computer-Aided Detection (CAD) framework can aid in identifying pulmonary nodules by investigating medical images. Automated CAD systems assist radiologists by reducing the diagnostic workload and increasing the possibility of early lung cancer identification. Finding and accurately outlining lung nodules is the specific task of lung nodule segmentation in medical image analysis. Methods: Multi-scale UNet, Feature Pyramid Network (FPN) with Linear Attention Mechanism and UNet with Asynchronous Convolution Blocks (ACB) and Channel Attention Mechanism were used to segment lung nodules. Multi-scale UNet improvises the traditional UNet architecture by incorporating multi-scale convolutional operations, which improves feature extraction and boosts segmentation accuracy. The UNet with ACB and Channel Attention Mechanism employs a cross-like receptive field that can reduce the impact of redundant information in obtaining representative characteristics. FPN with Linear Attention mechanism uses a multi-scale feature pyramid to identify nodules of different sizes and a linear attention mechanism is employed to improve feature extraction. FPN with Linear Attention mechanism attains a linear time and spatial complexity while effectively segmenting pulmonary nodules. Results and discussion: Employing the FPN with Linear Attention mechanism yielded the highest performance in the experiments. The highest results in the study using FPN with Linear Attention were achieved using GELU on the LIDC-IDRI dataset with a DSC of 71.59% and IoU of 58.57%. The smooth, probabilistic weighting of GeLU complements the model's attention mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.